Validation Manager

Finbiosoft joins forces with BYG4lab®

By March 14, 2024No Comments

SUBSCRIBE TO THE FINBIOSOFT BLOG

Get insights like this to your inbox, max twice a month.

Subscribe

We are thrilled to announce that Finbiosoft is now part of BYG4lab® Group! 🚀

BYG4lab® is a fast-growing leader in Middleware Data Management solutions in the healthcare industry. Established in France in 1982, today BYG4lab® caters to a global network of over 4000 laboratories.

“This agreement with Finbiosoft marks a significant step in BYG4lab®’s journey to become the global reference in data management software specialized in medical laboratory industry”, says Cyril Verhille, CEO of BYG4lab®.

“Since 2011, we have been providing software that enables laboratories and diagnostic companies to enhance quality and efficiency. We truly believe in the combined proposition we have to offer and, we look forward to working together with BYG4lab® to continue our journey together, in the interest of our customers and to build a great future for our employees”, says Akseli Virtanen, CEO of Finbiosoft.

Finbiosoft’s story and mission

In 2015, Finbiosoft launched Validation Manager – the market’s first cloud-based software service that enables diagnostic companies and laboratories to automate the verifications and validations of laboratory methods and instruments. Fast forward three years, Validation Manager had become the de-facto solution for laboratories in Finland. 

Today, our software service suite empowers customers across 16 European countries and the United States to reach higher quality and better efficiency in every aspect of their daily operation. We believe that joining forces with BYG4lab® will accelerate our ability to transform the way laboratories work, demonstrate competence, and ensure patient safety.

Looking forward to the future

Joining BYG4lab® Group not only means we become part of a family of over 110 colleagues but also unveils opportunities for scaling up and achieving exponential growth. While we pursue ambitious expansion for our product suite, our dedication to ensuring a seamless customer experience remains unchanged. 

We want to express our heartfelt gratitude to all teammates, customers, investors, and board members who have helped us reach this milestone. It’s an extraordinary opportunity and honor to help BYG4lab® enhance efficiency and cost-effectiveness in laboratories worldwide. We look forward to the future and continuing to help laboratories reach higher quality.

Teemu Qvick and Akseli Virtanen—Co-founders of Finbiosoft with Cyril Verhille—CEO of BYG4lab®

Accomplish more with less effort

See how Finbiosoft software services can transform the way your laboratory works.

Request a demo

Leave a Reply